[1] |
Tan TQ, Gerbie MV. Pertussis, a disease whose time has come: what can be done to control the problem?[J]. Obstet Gynecol,2013,122(2 Pt 1):370-373.
|
[2] |
张颖, 黄海涛, 刘勇, 等. 天津市社区人群百日咳发病监测及传播特征研究[J]. 中国疫苗和免疫,2011,17(3):209-211.
|
[3] |
胡云鸽, 刘泉波. 儿童百日咳247例临床特点及重症百日咳危险因素分析[J]. 中华儿科杂志,2015,53(9):684-689.
|
[4] |
Kenyon TA, Izurieta H, Shulman ST, et al. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness[J]. Pediatr Infect Dis J,1996,15(8):655-661.
|
[5] |
Bowden KE, Weigand MR, Peng Y, et al. Genome structural diversity among 31 bordetella pertussis isolates from two recent U.S. whooping cough statewide epidemics[J]. mSphere,2016,1(3):e00036-16.
|
[6] |
Clarke M, McIntyre PB, Blyth CC, et al. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis[J]. J Infect,2016,72(2):171-178.
|
[7] |
黄海涛, 高志刚. 百日咳再现及其应对策略的研究进展[J]. 医学综述,2015,21(9):1630-1632.
|
[8] |
王丽婵, 马霄, 孟丽, 等. 百日咳疫苗免疫接种策略及相关研究进展[J]. 中华预防医学杂志,2013,47(1):70-73.
|
[9] |
Souder E, Long SS. Pertussis in the era of new strains of bordetella pertussis[J]. Infect Dis Clin North Am,2015,29(4):699-713.
|
[10] |
Barlow RS, Reynolds LE, Cieslak PR, et al. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012[J]. Clin Infect Dis,2014,58(11):1523-1529.
|
[11] |
Clark TA. Changing pertussis epidemiology: everything old is new again[J]. J Infect Dis,2014,209(7):978-981.
|
[12] |
Hozbor D, Mooi F, Flores D, et al. Pertussis epidemiology in Argentina: trends over 2004-2007[J]. J Infect,2009,59(4):225-231.
|
[13] |
王传清, 朱启镕. 百日咳与非百日咳迁延性慢性咳嗽儿童及青少年临床特征分析[J]. 临床儿科杂志,2010,28(6):542-544.
|
[14] |
Wang K, Bettiol S, Thompson MJ, et al. Symptomatic treatment of the cough in whooping cough[J]. Cochrane Database Syst Rev,2014,22(9):CD003257.
|
[15] |
Foxwell AR, McIntyre P, Quinn H, et al. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia[J]. Pediatr Infect Dis J,2011,30(2):161-163.
|
[16] |
Phadke VK, Bednarczyk RA, Salmon DA, et al. Association between vaccine refusal and vaccine-preventable diseases in the United States: A review of neasles and pertussis[J]. JAMA,2016,315(11):1149-1158.
|
[17] |
Briand V, Bonmarin I, Lévy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data[J]. Vaccine,2007,25(41):7224-7232..
|
[18] |
Aloe C, Kulldorff M, Bloom BR. Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States[J]. Proc Natl Acad Sci USA,2017,114(27):7101-7105.
|
[19] |
Murray EL, Nieves D, Bradley JS, et al. Characteristics of severe bordetella pertussis infection among infants ≤ 90 days of age admitted to Pediatric Intensive Care Units--Southern California, September 2009-June 2011[J]. J Pediatric Infect Dis Soc,2013,2(1):1-6.
|
[20] |
Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization[J]. Expert Rev Vaccines,2014,13(9):1115-1123.
|
[21] |
Winter K, Zipprich J, Harriman K, et al. Risk factors associated with infant deaths from pertussis: A case-control study[J]. Clin Infect Dis,2015,61(7):1099-1106.
|
[22] |
Kuperman A, Hoffmann Y, Glikman D, et al. Severe pertussis and hyperleukocytosis: is it time to change for exchange?[J]. Transfusion, 2014,54(6):1630-1633.
|
[23] |
Rowlands HE, Goldman AP, Harrington K, et al. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants[J]. Pediatrics,2010,126(4):e816-827.
|